GLP-1 Revolution Meets AI! Nandan Kulkarni Reveals India’s Next Pharma Opportunity | Business News

GLP-1 Revolution Meets AI! Nandan Kulkarni Reveals India’s Next Pharma Opportunity | Business News

Indian biopharma is entering a new phase driven by AI, innovation and breakthrough therapies.

At ET NOW Markets Summit 2026, Nandan Kulkarni of Bernstein Research shares his outlook on how emerging trends like GLP-1 therapies, technology adoption and supply chain diversification could shape the next growth cycle for Indian pharma.

#etnowmarketssummit2026 #pharma #indianpharma #biopharma #ai #artificialintelligence #glp1

control your money with economic times now.
#etnow #businessnews #budget2026withetnow

YouTube Channel - https://www.youtube.com/@ETNow

Subscribe To ET Now For Latest Updates On Stocks Market News , Business News, Company News, IPO & More | https://bit.ly/SubscribeToETNow

Subscribe Now To Our Network Channels :-
ET Now Swadesh: https://www.youtube.com/etnowswadesh
Times Now: http://goo.gl/U9ibPb
Social Media Links :-
Twitter - http://goo.gl/hA0vDt
Facebook - http://goo.gl/5Lr4mC

Website - https://www.etnownews.com
Download our App for Breaking News: https://tinyurl.com/4y6e3u2e
Follow us on Google News for latest updates
ET Now: https://news.google.com/publications/CAAqBwgKMK3HxQsw0OLcAw?hl=en-IN&gl=IN&ceid=IN%3Aen
Times Now Navbharat: https://bit.ly/3zDaKJo
Times Now : https://bit.ly/3CyrrYg
Zoom: https://bit.ly/3CEK0dv

Видео GLP-1 Revolution Meets AI! Nandan Kulkarni Reveals India’s Next Pharma Opportunity | Business News канала ET Now